Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-24

FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

FDA approves a supplemental application for Children's ZYRTEC (cetirizine hydrochloride) to update labeling/indications submitted by Kenvue Brands LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHILDRENS ZYRTEC (cetirizine hydrochloride)

Snippet

SUPPL AP for CHILDRENS ZYRTEC (CETIRIZINE HYDROCHLORIDE)